Spiroindolinone derivatives
US7495007B2 · kind B2 · utility
21Cited by
1References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2007 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Aug 29, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to spiroindolinone derivatives of the formulaand their enantiomers and pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4, R5, R6, R7 and R8, are as herein described.The compounds have utility as antiproliferative agents, especially, as anticancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.